These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 11035376

  • 1. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
    Wu BY, Guo KY, Song CY, Yang, Li D.
    Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
    [Abstract] [Full Text] [Related]

  • 2. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G, Truitt RL, Johnson BD.
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [Abstract] [Full Text] [Related]

  • 3. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism.
    Mapara MY, Kim YM, Marx J, Sykes M.
    Transplantation; 2003 Jul 27; 76(2):297-305. PubMed ID: 12883182
    [Abstract] [Full Text] [Related]

  • 4. Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.
    Yang I, Weiss L, Abdul-Hai A, Kasir J, Reich S, Slavin S.
    Cancer Res; 2005 Nov 01; 65(21):9735-40. PubMed ID: 16266994
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
    Wu B, Guo K, Song Z, Yan D, Yang Y, Xiao L.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr 01; 23(4):194-7. PubMed ID: 12133456
    [Abstract] [Full Text] [Related]

  • 11. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Masmas TN, Dickmeiss E, Heilmann C, Vindeløv LL.
    Biol Blood Marrow Transplant; 2004 May 01; 10(5):337-46. PubMed ID: 15111933
    [Abstract] [Full Text] [Related]

  • 12. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.
    Sprangers B, Van Wijmeersch B, Fevery S, Waer M, Billiau AD.
    Nat Clin Pract Oncol; 2007 Jul 01; 4(7):404-14. PubMed ID: 17597705
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
    Chiorean EG, DeFor TE, Weisdorf DJ, Blazar BR, McGlave PB, Burns LJ, Brown C, Miller JS.
    Biol Blood Marrow Transplant; 2004 Mar 01; 10(3):171-7. PubMed ID: 14993882
    [Abstract] [Full Text] [Related]

  • 15. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H, Yamaguchi M, Kotani T, Sugimori N, Sugimori C, Ozaki J, Kondo Y, Yamazaki H, Chuhjo T, Takami A, Ueda M, Ohtake S, Nakao S.
    Eur J Haematol; 2007 Feb 01; 78(2):157-60. PubMed ID: 17313562
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
    Boeck S, Hamann M, Pihusch V, Heller T, Diem H, Rolf B, Pihusch R, Kolb HJ, Pihusch M.
    Bone Marrow Transplant; 2006 Jan 01; 37(1):57-64. PubMed ID: 16258529
    [Abstract] [Full Text] [Related]

  • 17. Anti-T-lymphocyte globulin based non-myeloablative stem cell transplantation followed by HLA-identical donor lymphocyte infusion for hematologic malignancies.
    Mao P, Wang S, Wang H, Li Q, Xu Y, Mo W, Ying Y, Zhu Z.
    Chin Med J (Engl); 2003 Jan 01; 116(1):70-3. PubMed ID: 12667392
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity.
    Durakovic N, Radojcic V, Powell J, Luznik L.
    Transplantation; 2007 Mar 15; 83(5):631-40. PubMed ID: 17353785
    [Abstract] [Full Text] [Related]

  • 20. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Mar 15; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.